- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05620303
24-h Movement Behaviors and Adherence to the Mediterranean Diet in Children
March 24, 2023 updated by: University of Castilla-La Mancha
A Healthy Lifestyle-based Randomized Controlled Trial on 24-h Movement Behaviors and Adherence to the Mediterranean Diet in Schoolchildren - The Archena Infancia Saludable Project: A Protocol Study
The purpose of this study is to determine the effects of the Archena Infancia Saludable project on adherence to MD and 24-h movement behaviors in schoolchildren
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
154
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Murcia, Spain, 30600
- Colegio El Ope
-
Contact:
- José Francisco López-Gil, PhD
- Email: josefranciscolopezgil@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 years to 13 years (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
Schoolchildren aged 6-13 years will be eligible
Exclusion Criteria:
- Participants with any pathology that contraindicate exercise or that request special attention.
- Participants under pharmacological treatment that prevent them from receiving the contents of the activities of the program.
- Participants or parents/legal guardians presenting Spanish learning difficulties.
- Participants do not authorized by the parents/guardians to be included in the research project.
- Participants do not agree to take part in the research project.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control group
|
|
Experimental: Exercise group
|
Parents/guardians will receive three different contents weekly (i.e., infographics, video recipes, information pills, or videos) each week related to 24-h movement behaviors (i.e., PA, sedentary behavior, sleep duration) or Mediterranean Diet for 36 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adherence to the Mediterranean diet
Time Frame: From baseline to 36 weeks later
|
To assess the adherence to the Mediterranean Diet, the Mediterranean Diet Quality Index for Children and Teenagers (KIDMED) index will be used.
|
From baseline to 36 weeks later
|
24-h movement behaviors (accelerometers) sedentary time
Time Frame: From baseline to 36 weeks later
|
A tri-axial accelerometer (Actigraph GT3x, Pensacola, FL, USA) will be used to assess sedentary time over seven consecutive days.
|
From baseline to 36 weeks later
|
24-h movement behaviors (self-reported)
Time Frame: From baseline to 36 weeks later
|
Self-report of physical activity levels and sedentary behaviors in youth will assessed by the Youth Activity Profile - Spain.
In this questionnaire, a rating scale is used with a score from 1 to 5 in which, in the first two sections, "1" indicates low intensity and frequency of physical activity and "5" indicates high intensity and frequency of physical activity; while, in the third section, "1" indicates a low amount of sedentary behaviors and "5" an excess of them.
|
From baseline to 36 weeks later
|
24-h movement behaviors (accelerometers) physical activity
Time Frame: From baseline to 36 weeks later
|
A tri-axial accelerometer (Actigraph GT3x, Pensacola, FL, USA) will be used to assess physical activity over seven consecutive days.
|
From baseline to 36 weeks later
|
24-h movement behaviors (accelerometers) sleep duration
Time Frame: From baseline to 36 weeks later.
|
A tri-axial accelerometer (Actigraph GT3x, Pensacola, FL, USA) will be used to assess sleep duration over seven consecutive days.
|
From baseline to 36 weeks later.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anthropometrics measurements
Time Frame: From baseline to 36 weeks later
|
The body weight of the schoolchildren will be measured using an electronic scale (with an accuracy of 0.1 kg) (Tanita BC-545, Tokyo, Japan), while height will be determined by a portable height rod with an accuracy of 0.1 cm (Leicester Tanita HR 001, Tokyo, Japan).
Body mass index (BMI) will be calculated by dividing body weight (in kg) by the height (in squared meters).
Furthermore, BMI z-score will be computed by the WHO age-specific and sex-specific thresholds.
|
From baseline to 36 weeks later
|
Active transportation
Time Frame: From baseline to 36 weeks later
|
Active transportation to and from school is evaluated by a self-reported questionnaire (Mode and Frequency of Commuting To and From School Questionnaire).
Participants were categorized as "active" if reported: ≥2 active travel days out of 5 school days (questions #1 and #2) and ≥ 4 active travel trips out of 10 school trips per week (question #3).
The usual mode of commuting to/from school was categorized as active when participants reported ≥ 1 active travel per day out of 2 daily school trips (question #4).
Those who were not categorized as "active commuting" were categorized as "passive commuting" users.
|
From baseline to 36 weeks later
|
Resting blood pressure
Time Frame: From baseline to 36 weeks later
|
Resting blood pressure will be measured using an automated blood pressure monitor with a fittingly sized cuff (Omrom® EVOLV HEM-7600T-E, Health-care Co, Kyoto, Japan).
First, schoolchildren will be seated in a quiet room for 10 min with their feet on the ground and their back supported.
Two readings will be taken, with the second blood pressure reading taken five min after the first.
The average of the two measurements for systolic blood pressure and diastolic blood pressure will be retained.
Subsequently, mean arterial pressure will be computed by the following formula: diastolic blood pressure + [0.333 × (systolic blood pressure - diastolic blood pressure)].
|
From baseline to 36 weeks later
|
Sleep disorders
Time Frame: From baseline to 36 weeks later
|
Sleep disorders will be evaluated by the BEARS (B = Bedtime Issues, E = Excessive Daytime Sleepiness, A = Night Awakenings, R = Regularity and Duration of Sleep, S = Snoring) scale.
Any questions that are answered positively indicate a sleep problem.
|
From baseline to 36 weeks later
|
Health-related quality of life
Time Frame: From baseline to 36 weeks later
|
Health-related quality of life will be measured by Child Health Utility 9D (CHU9D).
The CHU9D consists of 9 dimensions: worried, sad, pain, tired, annoyed, schoolwork/homework, sleep, daily routine, ability to join in activities with five different levels representing increasing levels of severity within each dimension.
Furthermore, CHU9D scores will be used in cost-utility analyses.
|
From baseline to 36 weeks later
|
Self-reported physical fitness
Time Frame: From baseline to 36 weeks later
|
Self-reported physical fitness will be assessed by the International Fitness Scale (IFIS), which is composed of a 5-point Likert-scale items asking about the children' perceived global physical fitness, cardiorespiratory fitness, muscular fitness, speed-agility, and flexibility in comparison with their counterparts' physical fitness (very poor (1), poor (2), average (3), good (4), and very good (5)).
|
From baseline to 36 weeks later
|
Parents'/guardians' perception of their children's body mass index status
Time Frame: From baseline to 36 weeks later
|
This outcome will be evaluated with the following question: "In relation to his/her height, which of the following options best describes your child's weight: 1) substantially above normal, 2) slightly above normal, 3) normal, 4) below normal?".
|
From baseline to 36 weeks later
|
Academic performance
Time Frame: From baseline to 36 weeks later.
|
Academic records will be provided at the end of the academic year by the school.
Firstly, academic performance will be evaluated according to the grade obtained in Language, Mathematics, Language and Mathematics (combined), English, as well as the grade point average of these three subjects.
Secondly, academic performance will be assessed by computing the grade point average of all the subjects taken by the children.
|
From baseline to 36 weeks later.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
24-h movement behaviors (self-reported) parents/guardians
Time Frame: From baseline to 36 weeks later.
|
The level of physical activity and sitting time will be assessed by the International Physical Activity Questionnaire-short form (IPAQ-SF).
|
From baseline to 36 weeks later.
|
Adherence to the Mediterranean diet (parents/guardians)
Time Frame: From baseline to 36 weeks later.
|
Parents/guardians will be also administered a 17-item Mediterranean dietary questionnaire, a modified version of the previously validated questionnaire used in the PREDIMED trial designed to assess adherence to Mediterranean Diet.
Meeting with each of the 17 items relating to characteristic food habits will be scored with zero or one point.
Therefore, the total score will range from 0 to 17 points, with 0 points denoting no adherence to the MD and 17 meaning maximum adherence to the Mediterranean Diet.
|
From baseline to 36 weeks later.
|
Anthropometrics measurements (parents/guardians)
Time Frame: From baseline to 36 weeks later.
|
The body weight and body height of the parents/guardians will be self-reported.
Body mass index (BMI) will be computed by dividing body weight (in kg) by the height (in squared meters).
|
From baseline to 36 weeks later.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 2, 2022
Primary Completion (Anticipated)
July 31, 2023
Study Completion (Anticipated)
September 30, 2023
Study Registration Dates
First Submitted
November 9, 2022
First Submitted That Met QC Criteria
November 9, 2022
First Posted (Actual)
November 17, 2022
Study Record Updates
Last Update Posted (Actual)
March 28, 2023
Last Update Submitted That Met QC Criteria
March 24, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- UCLMCFE00085
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Physical Activity
-
Istinye UniversityCompletedPhysical Activity | Youth | Physical Activity Barriers | Physical Activity FacilitatorsTurkey
-
Istanbul Kültür UniversityWithdrawnPhysical Activity Level | Physical Activity Awareness
-
Georgetown UniversityUniversity of PennsylvaniaCompletedPhysical Activity | Motor ActivityUnited States
-
Assistance Publique - Hôpitaux de ParisTerminatedPhysical Activity | Physical DisabilityFrance
-
University of Colorado, DenverCompletedPhysical Activity | Physical ImpairmentUnited States
-
PXL University CollegeHasselt UniversityNot yet recruitingPhysical Activity - Digital Phenotyping - Activity Tracking
-
University of ExtremaduraThe Spanish Ministry of Science, Innovation and UniversitiesRecruitingPhysical Activity | Cognition | Physical Fitness | AdolescentsSpain
-
AdventHealth Translational Research InstituteWake Forest UniversityRecruiting
-
Wake Forest University Health SciencesMayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases... and other collaboratorsRecruitingPhysical ActivityUnited States
-
Wake Forest University Health SciencesMayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases... and other collaboratorsRecruiting
Clinical Trials on Exercise
-
University of Kansas Medical CenterRecruiting
-
National Institute of Neurological Disorders and...TerminatedTraumatic Brain InjuryUnited States
-
University of Texas, El PasoRecruitingKnee Osteoarthritis | Knee Pain Chronic | Central Pain SyndromeUnited States
-
Toronto Rehabilitation InstituteCompletedAcute Myeloid LeukemiaCanada
-
Sahmyook UniversityRecruitingChronic Nonspecific Neck PainKorea, Republic of
-
University of AlbertaWomen and Children's Health Research Institute, CanadaRecruitingType 1 Diabetes | Post-menopauseCanada
-
Uskudar UniversityCompleted
-
Yuksek Ihtisas UniversityCompletedDementia | Frailty | Cognitive Function | Reaction Time | Aerobic Exercise | Balance ExerciseTurkey
-
National Taiwan Normal UniversityCompletedAging | Cognitive DeclineTaiwan
-
Wayne State UniversityUnknown